doi:10.1136/bmj-2023-076410 92
Comparing retatrutide to other GLP-1 options for women Retatrutide vs semaglutide and tirzepatide: the outcome gap Understanding where retatrutide fits in the current landscape of weight-loss pharmacology helps you evaluate whether it is the right choice for your situation and what to expect if you are transitioning from another medication
G., Cacciamani, L., Merlino, L., Angeloni, A., Muzii, L., & Porpora, M
By staying up-to-date with the latest weight loss treatments and technologies, we ensure you receive the most effective and advanced solutions available
Flexible financing through Cherry is available for most patients, split into up to 26 monthly payments
In the second trial, SURPASS-2, tirzepatide administered at doses of 5 mg, 10 mg, or 15 mg showed superior efficacy compared to semaglutide (1 mg) in reducing body weight and HbA1c levels over 40 weeks in patients with T2DM inadequately controlled with metformin [66]